|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/11/22 Oncocyte Corp. 10-K 12/31/21 90:10M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.76M
2: EX-4.11 Instrument Defining the Rights of Security Holders HTML 27K
3: EX-10.43 Material Contract HTML 236K
4: EX-21 Subsidiaries List HTML 26K
5: EX-23.1 Consent of Independent Registered Public HTML 25K
Accounting Firm
6: EX-23.2 Consent of Independent Registered Public HTML 25K
Accounting Firm
7: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 31K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
15: R1 Cover HTML 97K
16: R2 Consolidated Balance Sheets HTML 139K
17: R3 Consolidated Balance Sheets (Parenthetical) HTML 43K
18: R4 Consolidated Statements of Operations HTML 104K
19: R5 Consolidated Statements of Comprehensive Loss HTML 43K
20: R6 Consolidated Statements of Shareholders' Equity HTML 97K
21: R7 Consolidated Statements of Cash Flows HTML 156K
22: R8 Organization, Description of the Business and HTML 53K
Liquidity
23: R9 Basis of Presentation and Summary of Significant HTML 153K
Accounting Policies
24: R10 Business Combinations HTML 224K
25: R11 Goodwill and Intangible Assets, net HTML 54K
26: R12 Shareholders? Equity HTML 49K
27: R13 Stock-Based Compensation HTML 134K
28: R14 Disaggregation of Revenues and Concentration Risk HTML 67K
29: R15 Income Taxes HTML 77K
30: R16 Right-of-use Assets, Machinery and Equipment, Net HTML 37K
and Construction in Progress
31: R17 Commitments and Contingencies HTML 89K
32: R18 Related Party Transactions HTML 45K
33: R19 Loan Payable to Silicon Valley Bank HTML 47K
34: R20 Quarterly Financial Data (Unaudited) HTML 67K
35: R21 Subsequent Events HTML 42K
36: R22 Basis of Presentation and Summary of Significant HTML 225K
Accounting Policies (Policies)
37: R23 Basis of Presentation and Summary of Significant HTML 48K
Accounting Policies (Tables)
38: R24 Business Combinations (Tables) HTML 131K
39: R25 Goodwill and Intangible Assets, net (Tables) HTML 54K
40: R26 Stock-Based Compensation (Tables) HTML 115K
41: R27 Disaggregation of Revenues and Concentration Risk HTML 72K
(Tables)
42: R28 Income Taxes (Tables) HTML 58K
43: R29 Right-of-use Assets, Machinery and Equipment, Net HTML 35K
and Construction in Progress (Tables)
44: R30 Commitments and Contingencies (Tables) HTML 62K
45: R31 Quarterly Financial Data (Unaudited) (Tables) HTML 65K
46: R32 Organization, Description of the Business and HTML 82K
Liquidity (Details Narrative)
47: R33 Schedule of Prepaid Expenses and Other Current HTML 38K
Assets (Details)
48: R34 Schedule of Reconciliation of Cash, Cash HTML 34K
Equivalents, and Restricted Cash (Details)
49: R35 Schedule of Common Stock Equivalents Excluded from HTML 33K
Computation of Diluted Net Loss Per Share of
Common Stock (Details)
50: R36 Basis of Presentation and Summary of Significant HTML 75K
Accounting Policies (Details Narrative)
51: R37 Schedule of Fair Value of Aggregate Merger HTML 49K
Consideration (Details)
52: R38 Schedule of Fair Value of Aggregate Merger HTML 33K
Consideration (Details) (Parenthetical)
53: R39 Schedule of Intangible Assets Acquired and HTML 65K
Liabilities Assumed (Details)
54: R40 Schedule of Identifiable Intangible Assets and HTML 34K
Estimated Useful Life (Details)
55: R41 Schedule of Fair Value of Contingent Consideration HTML 42K
Liability (Details)
56: R42 Schedule of Contingent Consideration, Measured at HTML 43K
Fair Value (Details)
57: R43 Schedule of Acquisition Intangible Assets HTML 44K
(Details)
58: R44 Summary of Acquisition Intangible Assets (Details) HTML 29K
(Parenthetical)
59: R45 Schedule of Condensed Statement of Operations HTML 49K
(Details)
60: R46 Business Combinations (Details Narrative) HTML 223K
61: R47 Schedule of Goodwill and Intangible Assets HTML 58K
(Details)
62: R48 Schedule of Intangible Assets Future Amortization HTML 41K
Expense (Details)
63: R49 Shareholders? Equity (Details Narrative) HTML 79K
64: R50 Summary of Stock Option Activity (Details) HTML 101K
65: R51 Schedule of Stock Options Outstanding, Vested and HTML 50K
Exercisable (Details)
66: R52 Summary of Stock-based Compensation Expense HTML 39K
(Details)
67: R53 Schedule of Assumptions Used to Calculate Fair HTML 35K
Value of Stock Options (Details)
68: R54 Stock-Based Compensation (Details Narrative) HTML 76K
69: R55 Schedule of Consolidated Revenues Attributable to HTML 39K
Products or Services (Details)
70: R56 Schedule of Consolidated Revenues Generated by HTML 46K
Unaffiliated Customers (Details)
71: R57 Schedule of Percentage of Consolidated Revenues HTML 38K
Attributable to Geographical Locations (Details)
72: R58 Schedule of Percentage of Total Consolidated HTML 37K
Accounts Receivables (Details)
73: R59 Schedule of Components of Deferred Tax Assets and HTML 56K
Liabilities (Details)
74: R60 Schedule of Income Tax Reconciliation (Details) HTML 45K
75: R61 Schedule of Unrecognized Tax Benefit (Details) HTML 35K
76: R62 Income Taxes (Details Narrative) HTML 80K
77: R63 Schedule of Right-of-use Assets, Machinery and HTML 41K
Equipment, Net, and Construction in Progress
(Details)
78: R64 Right-of-use Assets, Machinery and Equipment, Net HTML 28K
and Construction in Progress (Details Narrative)
79: R65 Schedule of Supplemental Cash Flow Information HTML 35K
Related to Operating and Financing Lease (Details)
80: R66 Schedule of Supplemental Balance Sheet Information HTML 60K
Related to Operating and Financing Leases
(Details)
81: R67 Schedule of Future Minimum Lease Commitments for HTML 65K
Operating and Financing Leases (Details)
82: R68 Commitments and Contingencies (Details Narrative) HTML 66K
83: R69 Related Party Transactions (Details Narrative) HTML 70K
84: R70 Loan Payable to Silicon Valley Bank (Details HTML 72K
Narrative)
85: R71 Schedule of Quarterly Financial Information HTML 79K
(Details)
88: XML IDEA XML File -- Filing Summary XML 161K
86: XML XBRL Instance -- form10-k_htm XML 2.12M
87: EXCEL IDEA Workbook of Financial Reports XLSX 145K
11: EX-101.CAL Inline XBRL Taxonomy Extension Calculation XML 220K
Linkbase Document -- ocx-20211231_cal
12: EX-101.DEF Inline XBRL Taxonomy Extension Definition Linkbase XML 850K
Document -- ocx-20211231_def
13: EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase XML 1.55M
Document -- ocx-20211231_lab
14: EX-101.PRE Inline XBRL Taxonomy Extension Presentation XML 1.19M
Linkbase Document -- ocx-20211231_pre
10: EX-101.SCH Inline XBRL Taxonomy Extension Schema Document -- XSD 238K
ocx-20211231
89: JSON XBRL Instance as JSON Data -- MetaLinks 461± 647K
90: ZIP XBRL Zipped Folder -- 0001493152-22-006677-xbrl Zip 520K
 | Download this zipped .zip folder |
| Files: | ex10-43.htm ex21.htm ex23-1.htm ex23-2.htm ex31-1.htm ex31-2.htm ex32-1.htm ex4-11.htm form10-k.htm form10-k_001.jpg form10-k_002.jpg form10-k_003.jpg form10-k_004.jpg ocx-20211231.xsd ocx-20211231_cal.xml ocx-20211231_def.xml ocx-20211231_lab.xml ocx-20211231_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/12/23 Oncocyte Corp. 10-K 12/31/22 94:11M M2 Compliance LLC/FA 4/06/23 Oncocyte Corp. 424B5 1:307K M2 Compliance LLC/FA 5/12/22 Oncocyte Corp. 10-Q 3/31/22 78:7.5M M2 Compliance LLC/FA 5/02/22 Oncocyte Corp. 10-K/A 12/31/21 12:649K M2 Compliance LLC/FA 4/18/22 Oncocyte Corp. 424B5 1:384K M2 Compliance LLC/FA 4/15/22 Oncocyte Corp. 424B5 1:440K M2 Compliance LLC/FA 4/13/22 Oncocyte Corp. 424B5 1:442K M2 Compliance LLC/FA |